(–)-2β-Carboisopropoxy-3β-(4-iodophenyl)tropane (RTI-121 IPCIT) is a stimulant drug used in scientific research which was developed in the early 1990s. RTI-121 is a phenyltropane based highly selective dopamine reuptake inhibitor and is derived from methylecgonidine.
This page contains content from the copyrighted Wikipedia article "RTI-121"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
